NO175594C - Fremgangsmåte for isolering av heparin-bindende hjerne-mitogen - Google Patents

Fremgangsmåte for isolering av heparin-bindende hjerne-mitogen

Info

Publication number
NO175594C
NO175594C NO890295A NO890295A NO175594C NO 175594 C NO175594 C NO 175594C NO 890295 A NO890295 A NO 890295A NO 890295 A NO890295 A NO 890295A NO 175594 C NO175594 C NO 175594C
Authority
NO
Norway
Prior art keywords
heparin
binding brain
hbbms
promotion
binding
Prior art date
Application number
NO890295A
Other languages
English (en)
Other versions
NO890295D0 (no
NO890295L (no
NO175594B (no
Inventor
Peter Bohlen
Peter Gautschi-Sova
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO890295D0 publication Critical patent/NO890295D0/no
Publication of NO890295L publication Critical patent/NO890295L/no
Publication of NO175594B publication Critical patent/NO175594B/no
Publication of NO175594C publication Critical patent/NO175594C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Insulated Conductors (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Insulating Materials (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
NO890295A 1988-01-25 1989-01-24 Fremgangsmåte for isolering av heparin-bindende hjerne-mitogen NO175594C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14783588A 1988-01-25 1988-01-25

Publications (4)

Publication Number Publication Date
NO890295D0 NO890295D0 (no) 1989-01-24
NO890295L NO890295L (no) 1989-07-26
NO175594B NO175594B (no) 1994-07-25
NO175594C true NO175594C (no) 1994-11-02

Family

ID=22523098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890295A NO175594C (no) 1988-01-25 1989-01-24 Fremgangsmåte for isolering av heparin-bindende hjerne-mitogen

Country Status (9)

Country Link
EP (1) EP0326075B1 (no)
JP (1) JPH01308300A (no)
AT (1) ATE94882T1 (no)
AU (1) AU624803B2 (no)
DE (1) DE68909254T2 (no)
DK (1) DK29889A (no)
ES (1) ES2058350T3 (no)
FI (1) FI890342A (no)
NO (1) NO175594C (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801426D0 (sv) * 1988-04-15 1988-04-15 Ulf Rothman Forfarande och medel for blodbehandling
US5126323A (en) * 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same
US6448381B1 (en) * 1990-01-08 2002-09-10 Barnes-Jewish Hospital DNA encoding heparin-binding growth factor
ATE154608T1 (de) * 1990-04-12 1997-07-15 Ebewe Arzneimittel Verwendung einer mischung von peptiden and aminosäuren für die prophylaxis oder behandlung von dementia
FR2665448A1 (fr) * 1990-08-01 1992-02-07 Paris Val De Marne Universite Procede d'obtention d'un peptide ayant une activite facteur de croissance, produit obtenu et son application comme medicament.
US5210026A (en) * 1990-08-20 1993-05-11 American Cyanamid Company Human mk gene and method of expression
US6511823B1 (en) * 1990-08-20 2003-01-28 American Cyanamid Corporation Heparin binding neurotrophic factor gene sequence
EP0535337A3 (en) * 1991-09-30 1993-05-19 American Cyanamid Company Cell growth inhibiting activities of heparin binding neurite-outgrowth promoting factor
EP0535336A3 (en) * 1991-09-30 1993-05-19 American Cyanamid Company Mk protein as cell growth inhibitor
FI980032A0 (fi) * 1998-01-09 1998-01-09 Heikki Matti Eemeli Rauvala Ny anvaendning av en heparin bindande, med tillvaext foerknippad molekyl
US6364912B1 (en) * 1999-09-17 2002-04-02 Depuy Orthopeaedics, Inc. Pleiotrophin-based compositions for enhancing connective tissue repair
US7888485B2 (en) 2003-03-26 2011-02-15 Georgetown University Anti-pleiotrophin antibodies and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0248088A4 (en) * 1985-11-22 1988-05-03 Teijin Ltd VASCULARIZATION FACTOR AND MANUFACTURING.
EP0241136A3 (en) * 1986-03-07 1989-12-27 The President And Fellows Of Harvard College Human class 1 heparin-binding growth factor
CA2005600A1 (en) * 1988-12-20 1990-06-20 Cal-Henrik Heldin Endothelial cell growth factor

Also Published As

Publication number Publication date
DE68909254D1 (de) 1993-10-28
DE68909254T2 (de) 1994-04-28
NO890295D0 (no) 1989-01-24
JPH01308300A (ja) 1989-12-12
DK29889A (da) 1989-07-26
ES2058350T3 (es) 1994-11-01
EP0326075B1 (en) 1993-09-22
AU624803B2 (en) 1992-06-25
NO890295L (no) 1989-07-26
FI890342A0 (fi) 1989-01-24
ATE94882T1 (de) 1993-10-15
AU2873789A (en) 1989-07-27
EP0326075A3 (en) 1989-10-18
DK29889D0 (da) 1989-01-24
EP0326075A2 (en) 1989-08-02
NO175594B (no) 1994-07-25
FI890342A (fi) 1989-07-26

Similar Documents

Publication Publication Date Title
IT1214505B (it) Procedimento per la preparazione di collageno e prodotti cosi'ottenuto.
NO175594C (no) Fremgangsmåte for isolering av heparin-bindende hjerne-mitogen
ATE125820T1 (de) Verfahren und zusammensetzungen zur heilung von geschwüren.
GR3026751T3 (en) Process for producing collagen fibres
DK2285A (da) Osteogen faktor og middel indeholdende denne faktor
DE69634301D1 (de) Methode zur behandlung von alzheimer mit einem von einer gliazelllinie stammenden neurotrophen protein (gdnf)
DK0429570T3 (da) Osteoinducerende præparater
HU902288D0 (en) Process for producing new epimers of 1-alpha-hydroxy-d vitamin and their derivatives as well as pharmaceutical preparatives containing these compounds
ES2042742T3 (es) Procedimiento para preparar furanonas antiinflamatorias.
DE69130497T2 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
ATE140920T1 (de) Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung
EP0548123A4 (en) Anti-inflammatory factor, method of isolation, and use
ES2038974T3 (es) Metodo para incrementar selectivamente la proporcion de componentes principales individuales del complejo antibiotico a/16686.
AT383123B (de) Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat
ES2012128A6 (es) Metodo de tratar plantas con acidos organicos que contienen azufre.
DK165375C (da) Fremgangsmaade til selektivt at foroege andelen af faktor a og/eller b0 eller pa og/eller pb i et antibiotikum a 40926-kompleks
MY103562A (en) Somatic embryogenesis and plant regeneration of cacao
DE68924545D1 (de) Verwendung von Chinolizin- und Chinolizinon-Derivaten zur Herstellung von Arzneimitteln.
DE3784308D1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
JPS6485019A (en) Method for cultivating plant
PT75592B (de) 1,2,3-thiadiazol-5-yl-harnstoff-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende mittel mit wuchsregulatorischer und entblaetternder wirkung
EP0299295A3 (en) Polyglycerol esters of lanolin acids, method for their production and their application as emulsifiers
DE3573256D1 (en) (6,11-dihydro-11-oxodibenz(b,e)oxepinyl)pentanoic acids and derivatives, a process and intermediates for their preparation and their use as medicaments
RU93037867A (ru) Способ лечения длительно незаживающих ран и трофических язв кожных покровов